What is the global market size of Digital PCR (dPCR) and Real-time PCR (qPCR) Market?

Digital PCR (dPCR) and Real-time PCR (qPCR) Market size was valued at USD 5341.6 billion in 2021 and is poised to grow from USD 5806.48 billion in 2022 to USD 12018.88 billion by 2030, growing at a CAGR of 8.8% in the forecast period (2023-2030).

Top Digital PCR (dPCR) and Real-time PCR (qPCR) Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Digital PCR (dPCR) and Real-time PCR (qPCR) Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Digital PCR (dPCR) and Real-time PCR (qPCR) industry players.

Digital PCR (dPCR) and Real-time PCR (qPCR) Market Competitive Landscape

Top Players in Digital PCR (dPCR) and Real-time PCR (qPCR) Market

Danaher Corporation (US)
Bio-Rad Laboratories, Inc. (US)
Merck KGaA (Germany)
Becton, Dickinson and Company (US)
Abbott Laboratories (US)
Qiagen N.V. (Germany)
Thermo Fisher Scientific, Inc. (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
Takara Bio, Inc. (Japan)
Agilent Technologies, Inc. (US)
GE Healthcare (US)
bioMérieux (France)
Fluidigm Corporation (US)
Roche Diagnostics (Switzerland)
Illumina, Inc. (US)
Siemens Healthineers (Germany)
PerkinElmer, Inc. (US)
LGC Limited (UK)
Bio-Techne Corporation (US)
Cambridge Epigenetix Ltd. (UK)

Digital PCR (dPCR) and Real-time PCR (qPCR) Market

Digital PCR (dPCR) and Real-time PCR (qPCR) Market Report Snapshots

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?

REQUEST FREE CUSTOMIZATION

FAQs

Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market size was valued at USD 10.1 billion in 2023 and is poised to grow from USD 10.92 billion in 2024 to USD 20.36 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

Global digital PCR (dPCR) and real-time PCR (qPCR) market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Danaher Corporation (US) ', 'Bio-Rad Laboratories, Inc. (US) ', 'Merck KGaA (Germany) ', 'Becton, Dickinson and Company (US) ', 'Abbott Laboratories (US) ', 'Qiagen N.V. (Germany) ', 'Thermo Fisher Scientific, Inc. (US) ', 'F. Hoffmann-La Roche Ltd. (Switzerland) ', 'Takara Bio, Inc. (Japan) ', 'Agilent Technologies, Inc. (US) ', 'GE Healthcare (US) ', 'bioMérieux (France) ', 'Fluidigm Corporation (US) ', 'Roche Diagnostics (Switzerland) ', 'Illumina, Inc. (US) ', 'Siemens Healthineers (Germany) ', 'PerkinElmer, Inc. (US) ', 'LGC Limited (UK) ', 'Bio-Techne Corporation (US) ', 'Cambridge Epigenetix Ltd. (UK)'

Several factors are responsible for the growth of the global digital PCR (dPCR) and real-time PCR (qPCR) market including growing prevalence of infectious diseases, increasing genetic disorders, and the successful execution of Human Genome project during the forecast period.

Increasing number of patients caused due to viral infections/diseases increased concerns in the healthcare sector. As a result, digital PCR techniques are on the trend for discovering the drug or biomarker for the viral diseases. Moreover, due to the improvement in digital PCR techniques, it helps to detect the rare cancer biomarkers. Thus, researchers can use digital droplet PCR (ddPCR) along with molecular biology techniques to find out the new cancer biomarkers.

North America is holding the largest market share with a revenue of more than 35.0% in 2021, and is still expected to retain the same during the forecast period, owing to the presence of supportive government regulations and various initiatives about the development of healthcare infrastructure, growing prevalence of infectious and genetic diseases in the region, and an availability of the key manufacturers in the region are all expected to drive the regional market over the forecast period. The United States and Canada are the prominent countries boosting the market growth.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Digital PCR (dPCR) and Real-time PCR (qPCR) Market

Report ID: SQMIG35J2038

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE

Top Digital PCR (dPCR) and Real-time PCR (qPCR) Companies

Digital PCR (dPCR) and Real-time PCR (qPCR) Market Competitive Landscape

Top Players in Digital PCR (dPCR) and Real-time PCR (qPCR) Market

Digital PCR (dPCR) and Real-time PCR (qPCR) Market

Digital PCR (dPCR) and Real-time PCR (qPCR) Market Report Snapshots

FAQs

What is the global market size of Digital PCR (dPCR) and Real-time PCR (qPCR) Market?

Who are the key vendors in the Digital PCR (dPCR) and Real-time PCR (qPCR) Market?

What is the key driver of Digital PCR (dPCR) and Real-time PCR (qPCR) Market?

What is the key market trend for Digital PCR (dPCR) and Real-time PCR (qPCR) Market?

Which region accounted for the largest share in Digital PCR (dPCR) and Real-time PCR (qPCR) Market?

Request Free Customization